ranQ
ranQ
ranQ
DirectoryIndustriesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The first Swiss company directory, built to boost AI visibility.

Product
  • Pricing
  • Directory
  • Industries
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint742,806 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselUmlaut.bio GmbH
Umlaut.bio GmbH Logo
Verified· 2 sources

Umlaut.bio GmbH

Summary

About the company

Umlaut.bio GmbH develops small‑molecule therapeutics that target specific tRNA modifications to influence signaling pathways involved in cancer and inflammatory diseases. The company’s approach focuses on inhibiting key steps in tRNA modification to prevent overactivation of multiple signaling molecules.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
✓ Offered1
Development of therapeutic small molecules against RNA modifications
Development of small molecules to inhibit tRNA modifications and influence mRNA stability; therapeutic approach for cancer, autoimmune and inflammatory diseases.

Knowledge

No knowledge articles yet

Once Umlaut.bio GmbH has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Umlaut.bio GmbH in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Umlaut.bio GmbH by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Umlaut.bio GmbH to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Aeschengraben 13
4051 Basel

At a glance

Legal form
Limited Liability Company
UID
CHE-162.427.402
Founded
2025 · 1 year
Last commercial register change
March 9, 2026
Employees
1 to 10

Similar companies

AS
Autolus Switzerland AG
Basel
LB
LuMit Basel AG
Basel
MT
Mosanna Therapeutics AG
Basel
MT
Mysthera Therapeutics AG
Basel
US
Urovant Sciences GmbH
Basel
VA
VectivBio AG
Basel
AB
Amyra Biotech AG
Basel
CT
CORETAG Therapeutics AG
Basel